$10.28
+0.64 (+6.64%)
Open$10.09
Previous Close$9.64
Day High$10.42
Day Low$9.75
52W High$17.65
52W Low$2.95
Volume—
Avg Volume2.35M
Market Cap744.02M
P/E Ratio8.63
EPS$0.94
SectorPharmaceuticals
Analyst Ratings
Buy
10 analysts
Price Target
+533.9% upside
Current
$10.28
$10.28
Target
$65.17
$65.17
$47.12
$65.17 avg
$100.64
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 179.53M | 176.40M | 195.82M |
| Net Income | 39.25M | 28.13M | 36.61M |
| Profit Margin | 21.9% | 16.0% | 18.7% |
| EBITDA | 43.74M | 50.64M | 56.07M |
| Free Cash Flow | 39.04M | 39.72M | 27.68M |
| Rev Growth | -2.9% | +12.2% | +10.8% |
| Debt/Equity | 0.71 | 0.72 | 0.74 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,107.08 | +0.45% | 40.9 | 1.03T |
| JNJ | Johnson & Johnson | $239.08 | +3.37% | 26.1 | 549.78B |
| MRK | Merck & Co. Inc. | $119.60 | +3.57% | 31.5 | 281.24B |
| PFE | Pfizer Inc. | $24.72 | -1.44% | 19.2 | 143.68B |
| BMY | Bristol-Myers Squibb Co | $55.53 | +1.52% | 18.5 | 110.27B |
| ZTS | Zoetis Inc | $76.84 | +1.25% | 12.5 | 33.00B |